Moreover, IGF signaling has been previously involved in keeping human lung cancer cell stemness while IGF1R downregulation, in conjunction with INSR inhibition, was more effective in blocking IGF- and insulin-mediated signaling and growth in cancer cells compared to single-receptor targeting alone [89, 90]. The gene discussed is IGF1; the disease is cancer.